JD Health International Inc. (HKG:6618)
Hong Kong
· Delayed Price · Currency is HKD 43.30
+0.90 (2.12%)
Jun 27, 2025, 4:08 PM HKT
JD Health International Market Cap
JD Health International has a market cap or net worth of 138.56 billion as of June 27, 2025. Its market cap has increased by 66.14% in one year.
Market Cap
138.56B
Enterprise Value
84.33B
Revenue
61.89B
Ranking
n/a
PE Ratio
30.82
Stock Price
43.30
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 138.56B, a decrease of -59.72%. That is a compound annual growth rate of -18.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 138.56B | 54.17% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | 477.66B | 38.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 248.50B |
| Hansoh Pharmaceutical Group Company | 174.21B |
| Innovent Biologics | 136.09B |
| WuXi Biologics | 104.57B |
| Sino Biopharmaceutical | 93.72B |
| CSPC Pharmaceutical Group | 91.21B |
| Akeso | 88.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 75.10B |